PTC Therapeutics, Inc.

NASDAQ (USD): PTC Therapeutics, Inc. (PTCT)

Last Price

49.86

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Profile
PTCT

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Matthew B. Klein F.A.C.S., M.D., M.S. Dr. Matthew B. Klein F.A.C.S., M.D., M.S.

Full Time Employees:  988 988

IPO Date:  2013-06-20 2013-06-20

CIK:  0001070081 0001070081

ISIN:  US69366J2006 US69366J2006

CUSIP:  69366J200 69366J200

Beta:  0.63 0.63

Last Dividend:  0.00 0.00

Dcf Diff:  31.22 31.22

Dcf:  -0.43 -0.43

Description

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Address

100 Corporate Court,
South Plainfield, NJ 07080, US

908 222 7000

http://www.ptcbio.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment